Full Episode
Friday, Nov 14
PBS NewsHour
  • Episodes
  • Podcasts
  • Newsletters
  • The Latest
  • Politics
    Politics
    • Brooks and Capehart
    • Politics Monday
    • Supreme Court
  • Arts
    Arts
    • CANVAS
    • Poetry
    • Now Read This
  • Nation
    Nation
    • Supreme Court
    • Race Matters
    • Essays
    • Brief But Spectacular
  • World
    World
    • Agents for Change
  • Economy
    Economy
    • Making Sen$e
    • Paul Solman
  • Science
    Science
    • The Leading Edge
    • ScienceScope
    • Basic Research
    • Innovation and Invention
  • Health
    Health
    • Long-Term Care
  • Education
    Education
    • Teachers' Lounge
    • Student Reporting Labs
  • For Teachers
    Education
    • Newshour Classroom
  • About
    • Feedback
    • Funders
    • Support
    • Jobs

Help us continue to be your leading source for trustworthy news and information

Take our 2025 PBS NewsHour audience survey

Take the survey
Geoff Bennett and Amna Nawaz for PBS NewsHour
PBS News

Get news alerts from PBS News

Turn on desktop notifications?

FDA

  • Full Episodes
  • Podcasts
  • Newsletters
  • Live

Apr 19

WATCH: FDA commissioner testifies in Senate as Supreme Court considers ruling on abortion drugs

By Mark Sherman, Associated Press

FDA Commissioner Robert Califf testified in the Senate as the Supreme Court leaves access to a widely used abortion pill untouched until at least Friday, while the justices consider whether to allow restrictions on the drug mifepristone to take effect.

Continue reading

Apr 18

FDA clears extra COVID booster for some high-risk, older Americans

By Lauran Neergaard, Associated Press

The Food and Drug Administration is allowing an extra dose of the omicron-targeted vaccine for anyone 65 and older if it's been four months since their last shot.

Continue reading

Apr 14

Supreme Court temporarily keeps FDA abortion pill rules in place

By Mark Sherman, Jessica Gresko, Associated Press

The Supreme Court has temporarily kept in place federal rules for use of an abortion drug, while it more fully considers the issues raised in a court challenge.

Continue reading

Apr 13

Watch 5:35
How abortion providers are navigating the swiftly-changing legal landscape

By Geoff Bennett, Karina Cuevas

The White House will ask the Supreme Court to intervene in the legal battle surrounding the abortion medication mifepristone. A federal appeals court ruled in favor of continuing access to the drug, but also limited its distribution through the mail…

Continue watching

Apr 08

Watch 3:03
News Wrap: Justice Department probes potential leak of Pentagon documents

In our news wrap Saturday, access to the abortion drug mifepristone is up in the air after dueling rulings from two federal judges, the DOJ launched an investigation into a potential leak of Pentagon documents detailing aid to Ukraine, China…

Continue watching

Apr 07

FDA approval of abortion pill mifepristone in limbo after 2 federal judges order conflicting rulings

By Paul J. Weber, Matthew Perrone, Associated Press

A federal judge in Texas has thrown into jeopardy the most common method of abortion in the U.S., ordering regulators to temporarily halt their approval of the drug mifepristone for abortion.

Continue reading

Mar 29

Watch 4:58
News Wrap: IAEA head says situation at Ukraine nuclear plant has worsened

In our news wrap Wednesday, the head of the UN nuclear agency says the situation at the Zaporizhzhia nuclear plant in Ukraine has worsened since September, the U.S. Senate moved to reclaim war-making powers for Congress, Pope Francis has been…

Continue watching

Mar 29

Narcan just got over-the-counter approval. Here’s what you need to know

By Geoff Mulvihill, Associated Press

The U.S. Food and Drug Administration on Wednesday approved selling naloxone without a prescription, setting the overdose-reversing drug on course to become the first opioid treatment drug to be sold over the counter.

Continue reading

Mar 10

Cancer can go undetected in dense breasts. A new FDA rule will require providers to inform patients of that risk

By Candice Norwood, The 19th

The FDA on Thursday announced new regulations requiring mammogram providers to inform patients about the density of their breasts, a factor that increases the risk of breast cancer and can require additional screenings in order to properly detect the disease.

Continue reading

Mar 07

FDA to recall 2 more eyedrop brands due to contamination risks

By Associated Press

U.S. health officials are alerting consumers about two more recalls of eyedrops due to contamination risks that could lead to vision problems and serious injury.

Continue reading

Jump to the First Page Previous Page
1 5 6 7 8 9 10 11 35
Next Page Jump to the Last Page

Support Provided By: Learn more

web ad

Educate your inbox

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Form error message goes here.

Thank you. Please check your inbox to confirm.

Full Episode
Friday, Nov 14
  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You
  • Friends of the News Hour
PBS News

© 1996 - 2025 NewsHour Productions LLC. All Rights Reserved.

PBS is a 501(c)(3) not-for-profit organization.

Sections

  • The Latest
  • Politics
  • Arts
  • Nation
  • World
  • Economy
  • Science
  • Health
  • Education

About

  • About Us
  • TV Schedule
  • Press
  • Feedback
  • Funders
  • Support
  • Newsletters
  • Podcasts
  • Jobs
  • Privacy
  • Terms of Use

Stay Connected

  • Facebook
  • YouTube
  • Instagram
  • X
  • TikTok
  • Threads
  • RSS

Subscribe to Here's the Deal with Lisa Desjardins

Form error message goes here.

Thank you. Please check your inbox to confirm.

Support our journalism

Support for News Hour Provided By

  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You